Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.

about

Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.

Item

http://www.wikidata.org/entity/Q51349898

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Urinary B cell activating fact ...... ers of active lupus nephritis.

@en

Urinary B cell activating factor

@nl

type

Item

label

Urinary B cell activating fact ...... ers of active lupus nephritis.

@en

Urinary B cell activating factor

@nl

prefLabel

Urinary B cell activating fact ...... ers of active lupus nephritis.

@en

Urinary B cell activating factor

@nl

P1476

Urinary B cell activating fact ...... ers of active lupus nephritis.

@en

P2093

A Aggarwal

http://www.w3.org/2001/XMLSchema#string

R Gupta

http://www.w3.org/2001/XMLSchema#string

R Misra

http://www.w3.org/2001/XMLSchema#string

S Chaurasia

http://www.w3.org/2001/XMLSchema#string

S K Mishra

http://www.w3.org/2001/XMLSchema#string

S Phatak

http://www.w3.org/2001/XMLSchema#string

V Agrawal

http://www.w3.org/2001/XMLSchema#string

P2860

APRIL modulates B and T cell immunity

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Intrarenal production of B-cell survival factors in human lupus nephritis.

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Urinary sCD25 as a biomarker of lupus nephritis disease activity.

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.

B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.

P304

376-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.12894

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27804111

http://www.w3.org/2001/XMLSchema#string

P932

5290236

http://www.w3.org/2001/XMLSchema#string